Stockreport

Fast-Tracking the $537B Cancer Cure: How Accelerated Approvals Reshaping Oncology in 2026 [Globe and Mail, The (Toronto, Canada)]

Oncolytics Biotech Inc. - Common Shares  (ONCY) 
Last oncolytics biotech inc. - common shares earnings: 11/12 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.oncolyticsbiotech.com
PDF is entering a high-velocity regulatory phase as genomics in cancer care expands toward a projected $69.16 billion by 2032 [1] . This massive growth is driven by the syst [Read more]